Chinese herbal medicine for hospitalized pneumonia patients
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether Chinese herbal medicine can help people hospitalized with pneumonia. It compares the herbal treatment to usual care to see if it improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized with pneumonia (either caught in the hospital or in the community).
- You are 18 years old or older.
- You can understand and sign a consent form to join the study.
- You do not have confusion, dementia, or mental illness that would prevent participation.
- You are not completely bedridden or unable to care for yourself long-term.
- You are not allergic to the treatment drugs used in the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a combination of a traditional Chinese herbal formula and bacteriophages (viruses that kill bacteria) to treat severe pneumonia caused by drug-resistant bacteria. The treatment is inhaled directly into the lungs and may help when standard antibiotics don't work.
This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.